William Blair Estimates 908 Devices Q1 Earnings

908 Devices Inc. (NASDAQ:MASS) – Investment analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of 908 Devices in a report released on Tuesday, January 14th. William Blair analyst M. Larew forecasts that the company will post earnings of ($0.37) per share for the quarter. The consensus estimate for 908 Devices’ current full-year earnings is ($1.99) per share. William Blair also issued estimates for 908 Devices’ Q2 2026 earnings at ($0.31) EPS, Q3 2026 earnings at ($0.28) EPS and Q4 2026 earnings at ($0.24) EPS.

Several other brokerages have also recently issued reports on MASS. Leerink Partners reiterated a “market perform” rating and set a $4.00 target price (down from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Stifel Nicolaus dropped their price objective on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Stephens reissued an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a report on Wednesday. Finally, Leerink Partnrs lowered 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th.

908 Devices Trading Down 0.3 %

MASS opened at $2.90 on Thursday. The business’s fifty day simple moving average is $2.39 and its 200-day simple moving average is $3.53. The company has a market capitalization of $100.98 million, a price-to-earnings ratio of -1.64 and a beta of 0.96. 908 Devices has a 12-month low of $1.81 and a 12-month high of $8.50.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. SG Americas Securities LLC purchased a new stake in 908 Devices during the third quarter valued at approximately $36,000. B. Riley Wealth Advisors Inc. purchased a new stake in shares of 908 Devices during the 3rd quarter valued at $45,000. Drive Wealth Management LLC acquired a new stake in shares of 908 Devices in the 3rd quarter worth $50,000. Townsquare Capital LLC purchased a new position in 908 Devices during the 3rd quarter worth $50,000. Finally, 49 Wealth Management LLC grew its stake in 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after buying an additional 4,343 shares during the last quarter. Hedge funds and other institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.